Skip to content

CALYPTE BIOMEDICAL CORP

Delisted

CIK 899426fmd_1ZN8B1DNCHEJ7XXWK6VM1GPBC0Manufacturing · Laboratory Analytical InstrumentsTemplate: Standard

Coverage: Jan 01, 2010 to Dec 31, 2012, 11 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012
Cost of revenue000
Research and development000
Selling, general and administrative111
Total operating expenses221
Operating income(1)(1)(1)
Interest expense100
Income before taxes9(1)(1)
Income tax expense0(0)0
Net income from continuing operations9(1)(1)
Net income9(1)(1)